SCHEMBL12866362

SCHEMBL12866362

COC(=O)C(N)Cc1ccc(Oc2cc(I)c(O)c(I)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.57
KMT2A Q03164 7/20 0.57
PPARG P37231 4/20 0.57
NR1I2 O75469 2/20 0.57
BLM P54132 2/20 0.57
AGTR2 P50052 1/20 0.57
THRB P10828 8/20 0.54
LMNA P02545 5/20 0.54
THRA P10827 5/20 0.54
USP2 O75604 4/20 0.54
HSD17B10 Q99714 3/20 0.54
ALDH1A1 P00352 3/20 0.54
TTR P02766 2/20 0.54
ADORA3 P0DMS8 2/20 0.54
PDE4D Q08499 2/20 0.54
PTGS2 P35354 2/20 0.54
MAPT P10636 2/20 0.54
NR3C1 P04150 1/20 0.54
CYP1A2 P05177 1/20 0.54
HTR1A P08908 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12866377 0.90 THRB (0.58) MEN1KMT2APPARGNR1I2BLM
SCHEMBL677606 0.86 MEN1 (0.74) MEN1KMT2APPARGNR1I2BLM
SCHEMBL9619480 0.86 MEN1 (0.74) MEN1KMT2APPARGNR1I2BLM
SCHEMBL2139921 0.86 MEN1 (0.74) MEN1KMT2APPARGNR1I2BLM
SCHEMBL12866348 0.86 MEN1 (0.78) MEN1KMT2APPARGNR1I2BLM
SCHEMBL7273637 0.85 ESR1 (0.55) ALDH1A1PTGS2MIFPCNA
SCHEMBL8369339 0.84 THRB (0.76) MEN1KMT2APPARGNR1I2BLM
SCHEMBL8369341 0.84 THRB (0.76) MEN1KMT2APPARGNR1I2BLM
Hydrochloric Acid SCHEMBL8825443 0.83 THRB (0.74) MEN1KMT2APPARGNR1I2BLM
Hydrochloric Acid SCHEMBL8825447 0.83 THRB (0.74) MEN1KMT2APPARGNR1I2BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110028554-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE UNIVERSITE JOSEPH FOURIER (FR) 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028554-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING DIIODOTHYRONINE AND THEIR THERAPEUTIC USE TPO, HSD3B2, THRB MEN1 692/4885KMT2A 2483/4885PPARG 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.